Skip to main content
. 2020 Sep 30;371:m3513. doi: 10.1136/bmj.m3513

Table 1.

Characteristics of critically ill patients with covid-19 with and without in-hospital cardiac arrest. Data are numbers (%) unless stated otherwise

Characteristic No cardiac arrest (n=4318, 86.0%) Cardiac arrest (n=701, 14.0%) P value
ICU beds
<50 1268/4318 (29.4) 434/701 (61.9) <0.001
50-99 1248/4318 (28.9) 144/701 (20.5) 0.031
≥100 1802/4318 (41.7) 123/701 (17.5) <0.001
Demographics
Age (years; mean (SD)) 60 (15) 63 (14) <0.001
 <45 647/4318 (15.0) 68/701 (9.7) <0.001
 45-64 1851/4318 (42.9) 277/701 (39.5) 0.003
 65-79 1419/4318 (32.9) 270/701 (38.5) <0.001
 ≥80 401/4318 (9.3) 86/701 (12.3) <0.001
Male sex 2707/4318 (62.7) 458/701 (65.3) 0.15
Race
 White (non-Hispanic) 1263/4318 (29.2) 150/701 (21.4) <0.001
 Black (non-Hispanic) 1280/4318 (29.6) 226/701 (32.2) 0.17
 Hispanic 484/4318 (11.2) 67/701 (9.6) 0.22
 Asian 248/4318 (5.7) 43/701 (6.1) 0.66
 Unknown 1043/4318 (24.2) 215/701 (30.7) <0.001
Body mass index (mean (SD))* 32 (8) 32 (9) 0.23
 <30 1725/4165 (41.4) 283/656 (43.1) 0.044
 30-34 1111/4165 (26.7) 189/656 (28.8) 0.72
 35-39 640/4165 (15.4) 76/656 (11.6) 0.007
 ≥40 689/4165 (16.5) 108/656 (16.5) 0.59
Coexisting conditions and risk factors
Current or former tobacco use* 1861/3756 (49.5) 313/564 (55.5) 0.007
Diabetes mellitus 1770/4318 (41.0) 340/701 (48.5) <0.001
Hypertension 2611/4318 (60.5) 475/701 (67.8) <0.001
Coronary artery disease 563/4318 (13.0) 113/701 (16.1) 0.001
Congestive heart failure 434/4318 (10.1) 78/701 (11.1) 0.17
Chronic obstructive pulmonary disease 377/4318 (8.7) 56/701 (8.0) 0.52
Chronic or end stage kidney disease 671/4318 (15.5) 148/701 (21.1) <0.001
Active malignancy 188/4318 (4.4) 39/701 (5.6) 0.07
Laboratory values on day of ICU admission (median (IQR))
White cell count (per mm3) 8.2 (5.9-11.5) 10.1 (7-14.3) <0.001
Lymphocyte count (per mm3) 10.1 (6.2-15.5) 8.3 (4.8-13.6) <0.001
Hemoglobin (g/dL) 12.6 (14-11) 12.3 (10.6-13.8) 0.009
Platelet count (103/μL) 214 (163-276) 222 (165-285) 0.16
Creatinine (mg/dL) 1.03 (0.79-1.59) 1.4 (0.92-2.49) <0.001
Albumin (g/dL) 3.2 (2.8-3.6) 3.1 (2.7-3.5) <0.001
Aspartate aminotransferase (U/L) 51 (35-80) 64 (39-109) <0.001
Alanine aminotransferase (U/L) 35 (22-59) 40 (24-68) <0.001
Total bilirubin (mg/dL) 0.6 (0.4-0.8) 0.6 (0.4-0.9) <0.001
Lactate (mmol/L) 1.5 (1.1-2.2) 2.1 (1.3-3.1) <0.001
Arterial pH 7.38 (7.31-7.44) 7.33 (7.239-7.41) <0.001
D dimer (ng/mL) 1142 (610-2800) 2380 (1220-8200) <0.001
C reactive protein (mg/L) 146 (77.5-225) 173 (95.3-261) <0.001
Ferritin (ng/mL) 938 (464-1843) 1234 (604-2653) <0.001
mSOFA score on ICU admission (mean (SD)) 4.1 (3.1) 6.0 (3.3) <0.001
Complications‡
Invasive mechanical ventilation 3172/4318 (73.5) 491/701 (70.0) 0.029
Extracorporeal membrane oxygenation 174/4318 (4.0) 2/701 (0.3) <0.001
Newly diagnosed reduced left ventricular function§ 118/4318 (2.7) 48/701 (6.8) <0.001
Receipt of at least two vasopressors 1255/4318 (29.1) 362/701 (51.6) <0.001
Acute kidney injury requiring RRT 842/4318 (19.5) 161/701 (23.0) 0.033
Outcomes
ICU length of stay (days; median (IQR)) 17 (9-30) 6 (4-10) <0.001
Survived and discharged from hospital 2759/4318 (63.9) 48/701 (6.8) <0.001
Died while in hospital 1390/4318 (32.2) 653/701 (93.2) <0.001
Still in hospital 30 days after ICU admission 169/4318 (3.9) 0/701 (0.0)

ICU=intensive care unit; IQR=interquartile range; mSOFA=modified sequential organ failure assessment score; RRT=renal replacement therapy; SD=standard deviation.

*

Denominator differs in variables for smoking and body mass index because of missing data for these specific variables (listed in supplementary appendix).

Definitions of coexisting conditions are provided in supplementary appendix.

On ICU admission for non-cardiac arrest group, or before cardiac arrest.

§

Defined as newly diagnosed left ventricular ejection fraction less than 50% on echocardiogram.